A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial

American Heart Journal

Volumn 142, Issue 2, 2001, Pages 244-247

  Ross, Allan M ^a   Gao, Runlin ^b   Coyne, Karin S ^a   Chen, Jilin ^b   Yao, Kangbao ^b   Yang, Yuejin ^b   Qin, Xuewen ^b   Qiao, Shubin ^b   Yao, Min ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN; UROKINASE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; CHINA; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SCREENING; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034895320     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.116963     Document Type: Article

References (18)

1. A prospective, randomized, double-blind multicenter trial of a single bolus injection of the novel modified t-PA E6010 in the treatment of acute myocardial infarction: Comparison with native t-PA
2. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction
3. Population genetics of the angiotensin-converting enzyme in Chinese
4. Outcome of hypertension management in Asian Americans
5. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study
6. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: A comparison between the intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
7. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: Results of thrombolysis and angioplasty in myocardial infarction-phase 5 randomized trial
8. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
9. Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator: Increased fibrin(ogen)lysis in blacks
10. Race and prognosis after myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial
11. Antigens of tissue plaminogen activator and plasminogen activator inhibitor 1: Correlates in nonsmoking Japanese and Caucasian men and women
12. Expression of PAI-1, t-PA and u-PA in cultured human umbilical vein endothelial cells derived from racial groups
13. Hemostatic variables in Japanese and Caucasian men
14. Plasminogen phenotypes in a Japanese population
15. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients
16. New plasminogen activators
17. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 Trial
18. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes